Hexagon Nutrition Board Approves Q1 FY27 Results, Recommends Dividend
Hexagon Nutrition Limited approved Q1 FY27 results with total income of ₹1,063.84 million and net profit of ₹80.73 million. Board recommended a final dividend of ₹0.30 per share. AGM on September 22, 2026. Record date for dividend is September 15, 2026. Key management appointments and remuneration changes were also approved.
The approval of financial results, dividend recommendation, and key management changes are material events that can influence investor decisions. The AGM and record date provide clear future dates for stakeholders.
The company reported financial results and recommended a dividend, which are positive indicators. The appointment of new directors and reappointment of existing ones, along with remuneration adjustments, suggest continued operational focus.
Hexagon Nutrition Limited's Board of Directors, in a meeting held on August 12, 2026, approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also recommended a final dividend of ₹0.30 per equity share for the financial year ended March 31, 2026. The record date for this dividend is fixed as September 15, 2026. The 33rd Annual General Meeting (AGM) is scheduled for September 22, 2026, to be conducted via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). Book closure for the AGM will be from September 16 to September 22, 2026. Additionally, the board approved revisions in the annual remuneration for Chairman and Executive Director Mr. Arun Purushottam Kelkar, Managing Director Mr. Vikram Arun Kelkar, and Joint Managing Director Dr. Nikhil Arun Kelkar, subject to member approval. Mr. Arun Purushottam Kelkar's reappointment as Chairman & Director was also recommended. Mr. Raghunath Sawant was appointed as an Additional Executive Director effective August 12, 2026. The Articles of Association will be altered, subject to member approval. The IPO Committee has been dissolved following the successful completion of the IPO. The trading window will open 48 hours after the declaration of the financial results for the quarter ended June 30, 2026.
The financial results for the quarter ended June 30, 2026, show a total income of ₹1,063.84 million and a net profit of ₹80.73 million. The consolidated financial results also highlight a merger of Hexagon Nutrition (Exports) Private Limited with Hexagon Nutrition Limited, conversion of Compulsorily Convertible Preference Shares (CCPS) into equity shares on April 20, 2026, and the listing of equity shares on June 12, 2026. There is a material uncertainty regarding the going concern ability of two foreign subsidiaries, Hexagon Nutrition Proprietary Ltd and Hexagon Nutrition LLC, though the conclusion on the financial results is not modified.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.